Activities per year
Activities
- 1 - 50 out of 213 results
Search results
-
Risque thrombotique des oestroprogestatifs
Douxfils, J. (Speaker)
3 Apr 2025Activity: Talk or presentation types › Invited talk
-
Lower reporting of venous thromboembolisms events with natural estrogen-based COCs compared to ethinylestradiol containing pills: A disproportionality analysis of the Eudravigilance database.
Douxfils, J. (Speaker)
22 Mar 2025Activity: Talk or presentation types › Invited talk
-
Towards safer and more responsible use of estrogen-based oral contraceptives
Douxfils, J. (Speaker)
22 Mar 2025Activity: Talk or presentation types › Invited talk
-
Does E4/DRSP have minimal impact on hemostasis and VTE risk? The evidence is growing
Douxfils, J. (Speaker)
20 Mar 2025Activity: Talk or presentation types › Invited talk
-
Risque thrombotique des oestroprogestatifs : quoi de neuf ?
Douxfils, J. (Speaker)
13 Mar 2025Activity: Talk or presentation types › Invited talk
-
An in vitro cell based model for testing NETosis inhibitors and proNETotic agents.
Michaux, P. (Speaker), Bouarroudj, H. (Speaker) & Douxfils, J. (Speaker)
27 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Risque thromboembolique veineux de l’add back thérapie
Douxfils, J. (Speaker)
13 Mar 2025Activity: Talk or presentation types › Invited talk
-
Effect of E4/DRSP 15/3 mg on Hemostasis Parameters in Post-Menarchal Adolescents: A Phase 3 Multicentre Study
Douxfils, J. (Speaker)
20 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Vers une utilisation plus sûre et responsable des contraceptifs oraux à base d'estrogène
Douxfils, J. (Speaker)
11 Feb 2025Activity: Talk or presentation types › Invited talk
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
17 Dec 2024Activity: Talk or presentation types › Invited talk
-
The normalized Activated Protein C sensitivity ratio (nAPCsr): the INR of the gynecologist for a safer prescription of estrogen-containing products
Douxfils, J. (Speaker)
11 Dec 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
20 Jun 2024Activity: Talk or presentation types › Invited talk
-
Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Douxfils, J. (Speaker)
10 Jun 2024Activity: Talk or presentation types › Invited talk
-
Estetrol - an estrogen through life: Cardiovascular impact and the risk of VTE
Douxfils, J. (Speaker)
4 Jun 2024Activity: Talk or presentation types › Invited talk
-
Thromboses associées aux contraceptifs hormonaux combinés: évaluation du risque et suivi thérapeutique par un nouveau test, le nAPCr
Douxfils, J. (Speaker)
27 Jun 2024Activity: Talk or presentation types › Invited talk
-
Is there new data to support the screening of women for hereditary thrombophilia before prescribing pills?
Douxfils, J. (Speaker)
1 May 2024Activity: Talk or presentation types › Invited talk
-
Is there a physiological explanation to VTE risk observed in epidemiological studies?
Douxfils, J. (Speaker)
1 May 2024Activity: Talk or presentation types › Invited talk
-
Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using DOAC Dipstick in Various Indications
Harenberg, J. F. (Speaker), Ageno, W. (Speaker), Becattini, C. (Speaker), Douxfils, J. (Speaker), Falanga, A. (Speaker), Hetjens, S. (Speaker), Marchetti, M. (Speaker), Vassart, J. (Speaker), Violi, F. (Speaker), Weiss, C. (Speaker) & Weitz, J. I. (Speaker)
17 May 2024Activity: Talk or presentation types › Invited talk
-
DOACs and Reversal Agents
Douxfils, J. (Speaker)
10 Apr 2024Activity: Talk or presentation types › Invited talk
-
Thromboses associées aux contraceptifs hormonaux combinés: évaluation du risque et suivi thérapeutique par un nouveau test, le nAPCr
Douxfils, J. (Speaker)
18 Apr 2024Activity: Talk or presentation types › Invited talk
-
Cardiovascular safety: the point of view of the veins
Douxfils, J. (Speaker)
8 Mar 2024Activity: Talk or presentation types › Invited talk
-
Innovative biomarkers in sepsis
Douxfils, J. (Speaker)
28 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
16 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
22 Feb 2024Activity: Talk or presentation types › Invited talk
-
Rencontre Université de Namur - Faculté de Médecine et Clinique Saint-Luc de Bouge
Douxfils, J. (Contributor)
15 Feb 2024Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
Hormones-induced Coagulopathies — Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Douxfils, J. (Speaker)
25 Jan 2024Activity: Talk or presentation types › Invited talk
-
Innovative applications of global assays in hemostatis
Douxfils, J. (Jury Member)
15 Dec 2023Activity: Examinations › External Thesis
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Douxfils, J. (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Douxfils, J. (Invited speaker)
7 Nov 2023Activity: Talk or presentation types › Invited talk
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Safety profile of E4 Recent advance and evidence
Douxfils, J. (Speaker)
14 Nov 2023Activity: Talk or presentation types › Invited talk
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Douxfils, J. (Speaker) & Morimont, L. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
FIGO - XXIVe World Congress of Gynecology and Obstetrics
Douxfils, J. (Speaker)
9 Oct 2023 → 13 Oct 2023Activity: Participating in or organising an event types › Participation in conference
-
-
Safety profile of E4: Recent advance and evidence
Douxfils, J. (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Douxfils, J. (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Douxfils, J. (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Douxfils, J. (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Fantastic 4 - E4stetrol in Women's Health
Douxfils, J. (Invited speaker) & Foidart, J.-M. (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
APC resistance as a marker of the risk of VTE in users of oral contraceptives. Practical usefulness for industry and for clinicians
Douxfils, J. (Invited speaker)
26 May 2023Activity: Talk or presentation types › Invited talk
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Estétrol: une nouvelle ère dans la contraception
Douxfils, J. (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Douxfils, J. (Invited speaker) & Morimont, L. (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk
-
Global coagulation assays in the future of laboratory diagnostics of hemostasis and thrombosis - Interplay between platelets and coagulation
Douxfils, J. (Keynote speaker)
24 Nov 2022Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Douxfils, J. (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
Drug monitoring of direct oral anticoagulants: Key considerations and prespectives
Douxfils, J. (Speaker)
3 Nov 2022Activity: Talk or presentation types › Invited talk
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation